Delivery Order SPE2DB24D9210-SPE2DB25FZMZ2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price contract type with no set-aside designation. This delivery order represents a discrete purchase from DMS...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The contract, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on September 8, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order carries an ultimate completion date of September 9, 2025, and represents no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a discrete pharmaceutical fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36,976.24 by the Defense Logistics Agency (DLA) on July 31, 2025, with an ultimate completion date of August 1, 2025. The delivery order, issued under a firm fixed-price contract structure with no set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Performance will occur at the contractor's...
- The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on August 1, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. The delivery order, valued at $18,488.12 with a completion date of August 4, 2025, was awarded without set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform the work at its Park Ridge location and...
- The Defense Logistics Agency awarded a $26,827.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $18,488.12 for Trikafta 100-50-75 mg/150 mg oral units (84-count). This firm fixed-price delivery order, issued on May 6, 2025, with an ultimate completion date of May 7, 2025, represents a direct fulfillment of pharmaceutical supply needs under the company's existing Indefinite Delivery Contract with DLA. The award...
- The Defense Logistics Agency awarded a $36,976.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, valued at $18,488.12. The delivery order, which carries no set-aside designation, is for Trikafta 100-50-75 mg/150 mg tablets, a prescription medication used in the treatment of cystic fibrosis. The order is scheduled for completion by August 27, 2025, with performance taking...
- SPE2DB24D9210Indefinite Delivery Contract
- SPE2DB24D9210-SPE2DB25FZMZ2Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with DLA for diverse pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables. The company's core operations focus on distributing medications and medical supplies to Department of Defense healthcare facilities across the nation. As a certified woman-owned small business registered in the System for Award Management since 2001, DMS Pharmaceutical Group leverages its status to compete effectively in federal procurement markets while maintaining a robust portfolio of delivery orders for specialized pharmaceutical products ranging from contraceptive devices to oncology treatments and vaccines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 8/19/25 |